BioTechX is Europe’s largest congress covering diagnostics, precision medicine and digital transformation in pharmaceutical development and healthcare.
PrecisionLife CEO, Dr Steve Gardner, presents High Resolution Patient Stratification: Discovering Novel Targets and Developing Precision Medicines for Unmet Medical Needs in the AI in Drug Development track at 12:45 CET on Day 1 of the event.
Joining Steve at BioTechX will be:
The PrecisionLife team will be on Booth #113 and in the networking zone throughout the meeting.
Our scalable platform has delivered the deepest disease insights in over 40 complex, chronic indications, and a drug discovery pipeline of novel drug targets and precision drug repositioning opportunities for multiple conditions with unmet medical needs. These insights are protected and derisked by our unique and highly specific patient stratification biomarkers and are available for co-development with biopharma partners.
Send us a message to meet with us and discuss our partnering opportunities.
To see the agenda and register, visit the BioTechX website.